§ Mrs. LaitTo ask the Secretary of State for Health, pursuant to her answer of 17 March,Official Report, column 303, when she expects the Advisory Committee on National Health Service Drugs to specify which existing products in the 10 new categories to be covered by the selected list regulations it will formally consider; and on what basis the selection will be made.
§ Dr. MawhinneyThe Advisory Committee on National Health Service Drugs has set up sub-groups to undertake preliminary consideration, in the light of the committee's terms of reference, of the range of drugs within each of the new therapeutic categories. These sub-groups will report to the full committee, which will decide which drugs should be formally considered. The committee has not set dates for the reviews of particular categories, but relevant manufacturers will be informed in advance.
§ Mrs. LaitTo ask the Secretary of State for Health if she will place in the Library a list of the names of each product in each of the 10 therapeutic categories to be considered for inclusion in the selected list by the Advisory Committee on NHS Drugs.
§ Dr. MawhinneyI cannot add to my reply to the hon. Member on 17 March at column303.